71 results
8-K
EX-99.1
COCP
Cocrystal Pharma Inc
27 Aug 20
Cocrystal Pharma Increases Previously Announced Bought Deal to $15.0 Million
6:02am
commitment basis 14,285,715 shares of common stock of the Company, at a price to the public of $1.05 per share, less underwriting discounts and commissions
8-K
EX-99.1
COCP
Cocrystal Pharma Inc
5 May 21
Cocrystal Pharma Announces $40 Million Bought Deal Offering of Common Stock
7:52am
into an underwriting agreement with H.C. Wainwright & Co., LLC under which the underwriter has agreed to purchase on a firm commitment basis 26,000,000 shares
8-K
EX-99.1
COCP
Cocrystal Pharma Inc
27 Aug 20
Cocrystal Pharma Announces $10.0 Million Bought Deal Offering
12:00am
that it has entered into an underwriting agreement with H.C. Wainwright & Co., LLC under which the underwriter has agreed to purchase on a firm commitment
8-K
EX-10.2
1leqwoq
4 Mar 20
Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market
5:09pm
8-K
EX-2.1
7otes2
1 Dec 14
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-99.1
fmqb jc2ca
20 Mar 14
Index to Financial Statements
12:00am
8-K
EX-10.1
hr75n
24 Apr 17
Unregistered Sales of Equity Securities
12:00am
8-K
EX-10.1
fb1ur8solqrrfj4w
10 Apr 23
Cocrystal Pharma Completes $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30am
8-K
EX-2.1
jsurqcfcd5w7zek01
8 Jan 14
Completion of Acquisition or Disposition of Assets
12:00am
8-K
EX-1.1
s76naxidobg1y2tun
31 Jan 20
Entry into a Material Definitive Agreement
8:01am